Genus (LSE:GNS) Pre-Tax Income : £38.7 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Genus Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Genus's pretax income for the six months ended in Dec. 2023 was £14.3 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was £38.7 Mil. Genus's pretax margin was 4.29%.

During the past 13 years, Genus's highest Pretax Margin was 15.68%. The lowest was 1.66%. And the median was 8.64%.

Genus Pre-Tax Income Historical Data

The historical data trend for Genus's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus Pre-Tax Income Chart

Genus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Pre-Tax Income

Get a 7-Day Free Trial

9.90

46.30

55.80

48.40

39.40

Genus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															24.40	24.00	15.00	24.40	14.30

Competitive Comparison of Genus's Pre-Tax Income

For the Biotechnology subindustry, Genus's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genus's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genus's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Genus's Pre-Tax Income falls into.

Genus Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Genus's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	44	+	0	+	-14.3	+	1.1	+	8.6
	=	39.4

Genus's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	21.3	+	0	+	-10.5	+	2.1	+	1.4
	=	14.3

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £38.7 Mil.

Genus (LSE:GNS) Pre-Tax Income Explanation

Genus's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	14.3	/	333.6
	=	4.29%

During the past 13 years, Genus's highest Pretax Margin was 15.68%. The lowest was 1.66%. And the median was 8.64%.

Genus Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Genus's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus (LSE:GNS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (LSE:GNS) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

GENSF:USA GNSl:UK GBE:Germany

Address

Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ

Website

https://www.genusplc.com

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.